Treatment Updates in RCC
ASCO GU 2023 3-Year Follow-Up From The Phase 3 CheckMate 9ER Trial: Nivolumab + Cabozantinib vs. Sunitinib for 1L Treatment of Advanced RCC
By
ASCO GU 2023 Conference Coverage
FEATURING
Mauricio Burotto
By
ASCO GU 2023 Conference Coverage
FEATURING
Mauricio Burotto
Login to view comments.
Click here to Login
Treatment Updates in RCC